|Company name||Acadia Healthcare Company, Inc.|
|Class period||February 23, 2017 – October 24, 2017|
|Lead plaintiff deadline||December 3, 2018|
|Court||Middle District of Tennessee|
NEW YORK, November 16, 2018 – Bragar Eagel & Squire, P.C. announces that a class action lawsuit has been filed in the U.S. District Court for the Middle District of Tennessee on behalf of all persons or entities who purchased or otherwise acquired Acadia Healthcare Company, Inc. (NASDAQ: ACHC) securities between February 23, 2017 and October 24, 2017 (the “Class Period”). Investors have until December 3, 2018 to apply to the Court to be appointed as lead plaintiff in the lawsuit.
The complaint alleges that throughout the Class Period, defendants made materially false and misleading statements regarding Acadia’s business and operations, including by falsely stating that the quality of Acadia’s U.K. operations gave it a competitive strength that would drive future growth and profitability, and by issuing false and misleading guidance regarding the company’s actual and projected 2017 revenue, earnings before interest, taxes, depreciation and amortization and earnings per share.
If you purchased Acadia securities during the Class Period or continue to hold shares purchased before the Class Period, have information, would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Brandon Walker or Melissa Fortunato by email at firstname.lastname@example.org, or telephone at (212) 355-4648, or by filling out the contact form below. There is no cost or obligation to you.